238 related articles for article (PubMed ID: 21762097)
1. Genetic contributors to frontotemporal lobar degeneration: beyond monogenic disease.
Borroni B; Pilotto A; Bianchi M; Gilberti N; Padovani A
Mini Rev Med Chem; 2011 Oct; 11(11):988-1001. PubMed ID: 21762097
[TBL] [Abstract][Full Text] [Related]
2. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
[TBL] [Abstract][Full Text] [Related]
3. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal Lobar Degeneration.
Premi E; Padovani A; Borroni B
Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
[TBL] [Abstract][Full Text] [Related]
5. No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration.
Skoglund L; Ingvast S; Matsui T; Freeman SH; Frosch MP; Brundin R; Giedraitis V; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
Dement Geriatr Cogn Disord; 2009; 28(5):471-5. PubMed ID: 19940479
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study.
Gilberti N; Turla M; Alberici A; Bertasi V; Civelli P; Archetti S; Padovani A; Borroni B
Neurol Sci; 2012 Aug; 33(4):899-904. PubMed ID: 22127750
[TBL] [Abstract][Full Text] [Related]
7. Genetics of FTLD: overview and what else we can expect from genetic studies.
Pottier C; Ravenscroft TA; Sanchez-Contreras M; Rademakers R
J Neurochem; 2016 Aug; 138 Suppl 1():32-53. PubMed ID: 27009575
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
10. Clinical phenotypes and genetic biomarkers of FTLD.
Galimberti D; Scarpini E
J Neural Transm (Vienna); 2012 Jul; 119(7):851-60. PubMed ID: 22527778
[TBL] [Abstract][Full Text] [Related]
11. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.
Snowden JS; Pickering-Brown SM; Mackenzie IR; Richardson AM; Varma A; Neary D; Mann DM
Brain; 2006 Nov; 129(Pt 11):3091-102. PubMed ID: 17003069
[TBL] [Abstract][Full Text] [Related]
12. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
[TBL] [Abstract][Full Text] [Related]
13. The heritability and genetics of frontotemporal lobar degeneration.
Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
[TBL] [Abstract][Full Text] [Related]
14. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
[TBL] [Abstract][Full Text] [Related]
15. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
Irwin DJ; Cairns NJ; Grossman M; McMillan CT; Lee EB; Van Deerlin VM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Apr; 129(4):469-91. PubMed ID: 25549971
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.
Gasca-Salas C; Masellis M; Khoo E; Shah BB; Fisman D; Lang AE; Kleiner-Fisman G
PLoS One; 2016; 11(4):e0153852. PubMed ID: 27100392
[TBL] [Abstract][Full Text] [Related]
17. New insights into biological markers of frontotemporal lobar degeneration spectrum.
Borroni B; Alberici A; Archetti S; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2010; 17(10):1002-9. PubMed ID: 20156164
[TBL] [Abstract][Full Text] [Related]
18. Brain perfusion patterns in familial frontotemporal lobar degeneration.
Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
[TBL] [Abstract][Full Text] [Related]
19. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
[TBL] [Abstract][Full Text] [Related]
20. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
